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ABSTRACT 
Electrospray ionisation mass spectrometry (ESI-MS), absorption spectrophotometry and 
circular dichroism spectroscopy were used to investigate the non-covalent binding 
interactions of the nickel complexes [Ni(phen)2(L)]Cl2, (L = phen, dpq ,dpqc and dppz) 
with the 16mer oligonucleotide D2, which has the following base sequence: 
(GCTGCCAAATACCTCC/GGAGGTATTTGGCAGC). In addition, the extent of 
unwinding of the negatively supercoiled plasmid pUC9 caused by the nickel complexes, 
and the extent to which they inhibit in vitro synthesis of mRNA, were investigated using 
gel electrophoresis. The results of these studies showed that DNA binding strengthened as 
the size of the unique ligand was increased. Comparison of each of the above sets of results 
with those obtained from identical experiments performed using the analogous ruthenium 
complexes [Ru(phen)2(L)]
2+ (L = phen, dpq, dpqc, dppz) showed that varying the metal ion 
had a measurable effect on DNA binding affinity, with the nickel complexes generally 
interacting more weakly with D2 than the corresponding ruthenium complexes. 
ESI-MS/MS and in-source collision-induced dissociation experiments were performed 
using the tetrameric quadruplex DNA molecule Q5 (TTGGGGGT)4 and antiparallel 
dimeric quadruplex Q2 (GGGGTTTTGGGG)2 in order to determine their gas-phase 
dissociation profiles. It was found that the gas phase stability of the quadruplex DNA was 
dependent on its charge state, the number of oligonucleotide strands that make up the 
quadruplex, and the number of consecutive G-tetrads that it contains. ESI-MS and circular 
dichroism spectroscopy were also used to examine the non-covalent binding interactions of 
the octahedral nickel and ruthenium complexes stated above, as well as several square 
planar platinum complexes with Q5. The platinum complexes studied were 
 v 
[Pt(en)(phen)]2+, [Pt(en)(3,4,7,8-Me4phen)]
2+, [Pt(en)(4,7-Me2phen)]
2+ and  [Pt(5,6-
Me2phen)(S,S-dach)]
2+. The results obtained from these experiments showed that each of 
the three groups of metal complexes were able to bind to Q5. In contrast to what was found 
in experiments involving the duplex DNA molecule D2, the presence of the intercalating 
dppz ligand in the coordination sphere of both the nickel and ruthenium complexes did not 
greatly increase their binding affinity towards quadruplex DNA. This observation suggests 
that intercalative binding interactions may not play as important a role in the binding of 
metal complexes to quadruplex DNA. ESI-MS was used to analyse mixtures containing the 
organic drug daunomycin, Q5, and either [Ru(phen)2(dppz)]
2+ or  [Pt(en)(4,7-Me2phen)]
2+, 
in order to obtain information about the qDNA binding modes of these metal complexes. 
The affinity of the above two metal complexes towards parallel tetrameric quadruplexes 
with different lengths was also compared using ESI-MS in an attempt to shed light on 
whether they bind to the ends of the quadruplexes or in grooves along their lengths.  
The optimal conditions required to obtain ESI mass spectra of the non-covalent adduct 
formed between the DNA binding domain of mouse transcription factor PU.1, and a short  
10mer DNA molecule containing its 5'-GGAA-3' consensus sequence, were determined. 
ESI-MS was then used to probe the extent of inhibition of formation of this non-covalent 
complex caused by addition of [Ru(phen)2(dppz)]
2+ or [Pt(5,6-Me2phen)(S,S-dach)]
2+.  
Both metal complexes were shown to inhibit binding of the transcription factor to its DNA 
recognition site, demonstrating the potential of these complexes for transcription therapy. 
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ABBREVIATIONS 
 
A   adenine 
AML   acute myeloid leukemia 
bip    biphenyl 
Bqdi   1,2-benzoquinone diimine 
Bpy   bipyridine 
C   cytosine 
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 vii 
EI               electron ionisation 
en   (1,2-diaminoethane) 
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FAB   fast atom bombardment 
FD   field desorption 
FDA   food and drug administration 
G   guanine 
GSH   glutathione 
GST   glutathione-S-transferase 
HAT    1,4,5,8,9,12-hexaazatriphenylene 
HIF-1   hypoxia inducible factor 1α 
IκB   inhibitor of κB 
ICD   induced circular dichroism 
MALDI  matrix assisted laser desorption ionisation 
MGP   4-(guanidylmethyl)-1-10-phenanthroline 
MOPS                         3-(N-morpholino)propanesulfonic acid 
MS              mass spectrometry 
m/z   mass-to-charge 
NF-κB   nuclear factor-κB 
NH4OAc  ammonium acetate 
NMR   nuclear magnetic resonance 
PD   plasma desorption 
phi   9,10-phenanthrenequinone diimine 
phen   1,10-phenanthroline 
 viii 
Q-TOF  quadrupole time-of-flight 
qDNA                          quadruplex DNA 
RNA   ribonucleic acid 
R,R-Me2trien  2R,9R-diamino-4,7-diazadecane 
Sp1   Specficity Protein 1 
Stat3   Signal transducer and activator of transcription 
T   thymine 
TBACl   tetrabutylammonium  chloride 
terpy   2,2:6’2’’-terpyridine 
TFOs   triplex forming oligonucleotides 
TMPyP4  [tetra(N-methyl-4-pyridyl-porphine)] 
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yAP-1   yeast Activator Protein 1 
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